Novosibirsk Scientific Research Institute for Circulatory Pathology
5
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
The Effect of Polymorphism of the GUCY1A3 rs7692387 Gene on Cardiovascular Events After Coronary Artery Bypass Grafting.
Role: lead
Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE
Role: collaborator
Comparison of stAndard and Hybrid Surgical Techniques in the Treatment of proximaL Aortic dissEctions
Role: lead
Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Novosibirsk Region
Role: lead
Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy
Role: lead
All 5 trials loaded